Investegate |LumiraDx Inc Announcements | LumiraDx Inc: LumiraDx Reports Fourth Quarter and Full Year 2022 Results
Investegate announcements from LumiraDx Inc, LumiraDx Reports Fourth Quarter and Full Year 2022 Results
Stay updated with breaking news from Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from LumiraDx Inc, LumiraDx Reports Fourth Quarter and Full Year 2022 Results
On March 13, 2023, FDA issued a notice regarding guidance documents related to the COVID-19 pandemic, including which of the guidance documents will…
The real-time RT-PCR Simplexa COVID-19 & Flu A/B Direct assay is designed for use on the company's Liaison MDX instrument, with results in about one hour.
The COVID-19 pandemic presented the U.S. Food and Drug Administration (FDA or Agency) with a monumental task of shifting its operations and the way it approached the regulation of...
Since the beginning of the COVID-19 pandemic, the US Food and Drug Administration (FDA or the Agency) has issued more than 80 guidance documents describing flexibilities that would be...